[HTML][HTML] Care recommendations for the investigation and management of children with skeletal muscle channelopathies
E Matthews, J Palace, S Ramdas, V Sansone… - Pediatric Neurology, 2023 - Elsevier
The field of pediatric skeletal muscle channelopathies has seen major new advances in
terms of a wider understanding of clinical presentations and new phenotypes. Skeletal …
terms of a wider understanding of clinical presentations and new phenotypes. Skeletal …
[HTML][HTML] Effets de l'exercice physique sur les maladies musculaires
A Boulinguiez, D Bouragba, B Crisol… - médecine …, 2024 - medecinesciences.org
Les myopathies constituent un groupe hétérogène de maladies caractérisées par une
faiblesse et une dégénérescence progressive des muscles. Alors que ces maladies …
faiblesse et une dégénérescence progressive des muscles. Alors que ces maladies …
Pathogenic SCN5A Mutation and Thyrotoxicosis-Related Neurological Syndrome: Casual or Causal Relationship?
Y Xu, L Zhao, J Dong, J Jiang, L Jin - Brain Sciences, 2023 - mdpi.com
Background: Various neurologic complications of hyperthyroidism are reported, and most of
these complications are reversible with the amelioration of thyrotoxicosis. We report a …
these complications are reversible with the amelioration of thyrotoxicosis. We report a …
Periodic paralysis
SC Cannon - Handbook of clinical neurology, 2024 - Elsevier
Periodic paralysis is a rare, dominantly inherited disorder of skeletal muscle in which
episodic attacks of weakness are caused by a transient impairment of fiber excitability …
episodic attacks of weakness are caused by a transient impairment of fiber excitability …
Episodic flaccid muscle weakness (Periodic paralysis)
E Matthews - Neurogenetics for the Practitioner, 2024 - Elsevier
Episodic flaccid muscle weakness can occur with altered serum potassium levels. Causes
may be genetic (primary periodic paralysis) or secondary to a systemic condition that alters …
may be genetic (primary periodic paralysis) or secondary to a systemic condition that alters …
Myotone Dystrophien, nichtdystrophe Myotonien und periodische Paralysen
C Schneider-Gold, F Weber - DGNeurologie, 2024 - Springer
–Myotone Dystrophie Typ 2, nichtdystrophe Myotonien: aktuell keine laufenden Studien zu
neuen ursächlichen Therapien.–Eine neue Studie zu dem Karboanhydrasehemmer …
neuen ursächlichen Therapien.–Eine neue Studie zu dem Karboanhydrasehemmer …
[引用][C] The long exercise test: New insights on an old technique
E Logigian - Muscle & Nerve, 2022 - Wiley Online Library
See article on pages 581–585 in1 this issue